Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals") and Formation Biotoday announced Formation Bio's acquisition of worldwide rights, excluding Greater China, to ...
Formation Bio and Lynk Pharmaceuticals today announced Formation Bio's acquisition of worldwide rights, excluding Greater China, to LNK01006, a next generation central nervous system (CNS)–penetrant ...
US AI-focused start-up Formation Bio has entered a deal with Lynk Pharmaceuticals for worldwide rights, excluding Greater ...
Formation Bio is inking a deal worth more than $600 million in biobucks for ex-China rights to a next-gen immunology asset ...
Pilates is known as a relatively low-risk exercise modality—it's low-impact, done with lightweights, and is easily adaptable ...
NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI), a clinical-stage biopharmaceutical company developing brain-penetrant therapeutics for central nervous system (CNS) cancers, today announced newly ...
6d
BioAge Announces Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
BGE-102 was well-tolerated in SAD and initial MAD cohorts, with a pharmacokinetic profile supporting once-daily oral dosingStrong target ...
Singing and chanting can have profound benefits to physical, mental and social health, with both immediate and long-term effects ...
After a yearslong series of setbacks, NASA's Escape and Plasma Acceleration and Dynamics Explorers, or ESCAPADE, mission has ...
New ideas can shift everything you thought you understood, and these science books offer that rare spark that leaves your ...
Postpartum depression (PPD) affects up to one in five Canadian women1; it is the most common complication2 related to childbearing and a leading cause of maternal death in Canada3Left untreated, PPD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback